Shiva Biogenetic Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.32 Cr
as on 14-12-2024
- Paid Up Capital ₹ 2.25 Cr
as on 14-12-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 13.24 Cr
as on 14-12-2024
- Satisfied Charges ₹ 18.46 Cr
as on 14-12-2024
About Shiva Biogenetic Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.32 Cr and a paid-up capital of Rs 2.25 Cr.
The company currently has active open charges totaling ₹13.24 Cr. The company has closed loans amounting to ₹18.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Parsan Singh, Sushila Devi, Shailendra Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24032HP2005PTC010765
- Company No.
140862
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shiva Biogenetic Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parsan Singh  | Director | 13-May-2022 | Current |
| Sushila Devi | Director | 16-Sep-2005 | Current |
| Shailendra Singh | Director | 02-Feb-2007 | Current |
| Kapil Bhardwaj | Director | 27-Feb-2010 | Current |
Financial Performance of Shiva Biogenetic Pharmaceuticals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shiva Biogenetic Pharmaceuticals?
Unlock access to Shiva Biogenetic Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shiva Biogenetic Laboratories Private LimitedActive 8 years 5 monthsParsan Singh and Kapil Bhardwaj are mutual person
- Shiva Audax Pharmaceuticals Private LimitedActive 13 years 4 months
Shailendra Singh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 26 Nov 2021 | ₹2.00 Cr | Open |
State Bank Of India Creation Date: 03 Jan 2018 | ₹11.24 Cr | Open |
Axis Bank Limited Creation Date: 23 Jun 2014 | ₹1.60 Cr | Satisfied |
How Many Employees Work at Shiva Biogenetic Pharmaceuticals?
Unlock and access historical data on people associated with Shiva Biogenetic Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shiva Biogenetic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiva Biogenetic Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
